104 related articles for article (PubMed ID: 11914904)
1. Dihydropyrimidine dehydrogenase expression in preoperative biopsy and surgically resected specimens of gastric carcinoma.
Nozawa H; Tsukui H; Nishida K; Yakumaru K; Nagawa H; Sekikawa T
Cancer Chemother Pharmacol; 2002 Apr; 49(4):267-73. PubMed ID: 11914904
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer.
Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Takechi T; Okabe H; Fukushima M; Kitajima M
Anticancer Res; 1999; 19(6C):5635-40. PubMed ID: 10697632
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer.
Oi K; Makino M; Ozaki M; Takemoto H; Yamane N; Nakamura S; Ikeguchi M; Kaibara N
Anticancer Res; 2004; 24(1):273-9. PubMed ID: 15015608
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of immunoreactivity of dihydropyrimidine dehydrogenase (DPD) in gastric scirrhous carcinoma treated with S-1, a new DPD inhibitory fluoropyrimidine.
Shimizu T; Yamada Y; Yasui H; Shirao K; Fukuoka M
Anticancer Res; 2005; 25(4):2997-3001. PubMed ID: 16080558
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of dihydropyrimidine dehydrogenase (DPD) and p53 in biopsied specimens of esophageal cancer before chemoradiotherapy].
Hisamitsu K; Fukuda K; Oka S; Yamaguchi K; Katano K; Ikeguchi M; Tsujitani S; Kaibara N
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1527-9. PubMed ID: 11707971
[TBL] [Abstract][Full Text] [Related]
7. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody.
Tokunaga Y; Nakagami M; Tokuka A; Ohsumi K
Anticancer Res; 2003; 23(2C):1763-8. PubMed ID: 12820455
[TBL] [Abstract][Full Text] [Related]
8. Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer.
Nakayama Y; Inoue Y; Nagashima N; Katsuki T; Matsumoto K; Kadowaki K; Shibao K; Tsurudome Y; Hirata K; Sako T; Nagata N; Itoh H
Anticancer Res; 2005; 25(6A):3755-61. PubMed ID: 16302736
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma.
Sasaki H; Fukai I; Kiriyama M; Kaji M; Yano M; Yamakawa Y; Fujii Y
Surg Today; 2003; 33(2):83-8. PubMed ID: 12616366
[TBL] [Abstract][Full Text] [Related]
10. The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.
Oeda M; Yoshida K; Sanada Y; Wada Y; Suzuki T; Mizuiri H; Konishi K; Shigematsu H; Tanabe K; Fukushima M
Oncol Rep; 2006 Dec; 16(6):1165-72. PubMed ID: 17089033
[TBL] [Abstract][Full Text] [Related]
11. [Dihydropyrimidine dehydrogenase expression in gastric cancer using anti-human dihydropyrimidine dehydrogenase monoclonal antibody].
Kitago K; Ichikawa W; Uetake H; Nihei Z
Gan To Kagaku Ryoho; 2002 Feb; 29(2):245-52. PubMed ID: 11865631
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of immunohistochemical evaluation of dihydropyrimidine dehydrogenase for rectal cancer treated with preoperative radiotherapy.
Komuro Y; Watanabe T; Tsuno N; Kitayama J; Inagaki N; Nishida M; Nagawa H
Hepatogastroenterology; 2003; 50(52):906-11. PubMed ID: 12845947
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
Nakagawa T; Tanaka F; Takata T; Matsuoka K; Miyahara R; Otake Y; Yanagihara K; Fukushimab M; Wada H
J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
[TBL] [Abstract][Full Text] [Related]
14. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
Tokunaga Y; Takahashi K; Saito T
Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers.
Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
Oncol Rep; 2004 May; 11(5):1045-51. PubMed ID: 15069545
[TBL] [Abstract][Full Text] [Related]
16. Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stromal cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.
Hisamitsu K; Tsujitani S; Yamaguchi K; Fukuda K; Konishi I; Kaibara N
Anticancer Res; 2004; 24(4):2495-501. PubMed ID: 15330204
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase and dihydropyrimidine dehydrogenase expressions in gallbladder cancer.
Ajiki T; Hirata K; Okazaki T; Horiuchi H; Fujita T; Habara K; Kamigaki T; Suzuki Y; Kuroda Y
Anticancer Res; 2006; 26(2B):1391-6. PubMed ID: 16619549
[TBL] [Abstract][Full Text] [Related]
18. The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer.
Li Y; Mizutani Y; Shiraishi T; Nakamura T; Mikami K; Takaha N; Okihara K; Kawauchi A; Sakai T; Miki T
BJU Int; 2007 Mar; 99(3):663-8. PubMed ID: 17092280
[TBL] [Abstract][Full Text] [Related]
19. [Significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced gastric cancers].
Tsukayama S; Hirano M; Murakami N; Uno Y; Nozawa H; Yoshino H; Orta N; Kikkawa H; Masuda S
Gan To Kagaku Ryoho; 2001 May; 28(5):649-54. PubMed ID: 11383213
[TBL] [Abstract][Full Text] [Related]
20. The stability of dihydropyrimidine dehydrogenase activity in colorectal cancer tissue after resection.
Sadahiro S; Suzuki T; Ishikawa K; Nakamura T; Kamijo A; Saguchi T; Yasuda S; Tajima T; Makuuchi H; Murayama C
Oncol Rep; 2003; 10(4):867-9. PubMed ID: 12792736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
